alicon AG - breakthrough products setting a new standard in TSE diagnostics and prion filtration
Excerpted from the website:
- The Swiss biotechnology company alicon AG, founded in 2004, specializes in developing innovative technologies to detect and filtrate pathogenic prions in blood from animals and humans.
- Within the diagnostic sector, alicon is particularly active and well-positioned as a pioneer in developing the first ante mortem TSE testing procedures. The firm’s business concept is based on the design of a novel process that can confirm the presence of prions in blood from humans and animals.
- In the bio-safety sector, alicon is developing procedures allowing filtration of prions from blood plasma products and culture medium.